Fused bicyclic pyrimidones as wrn inhibitors
US-2026098041-A1 · Apr 9, 2026 · US
This page is not indexed by search engines while we improve data quality.
Wang xiaozhao patents
Wang xiaozhao is listed as an inventor on 155 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Wang xiaozhao |
| Total patents | 155 |
| First publication | Jan 6, 2015 |
| Latest publication | Apr 9, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Substituted 7h-pyrrolo[2,3-d]pyrimidin-2-amines as selective cdk2/4 inhibitors
US-2026070915-A1 · Mar 12, 2026 · US
Substituted pyrrolo[2,1-f][1,2,4]triazin-2-amines as cdk2 and cdk4 inhibitors
US-2026070914-A1 · Mar 12, 2026 · US
Kras inhibitors
US-2026069605-A1 · Mar 12, 2026 · US
Pyrrolotriazine compounds as tam inhibitors
US-2026042765-A1 · Feb 12, 2026 · US
Kras inhibitors
US-2026034126-A1 · Feb 5, 2026 · US
Bicyclic DGK Inhibitors
US-2026001880-A1 · Jan 1, 2026 · US
Quinoline compounds as inhibitors of kras
US-2025368641-A1 · Dec 4, 2025 · US
Fused bicyclic pyrimidones as wrn inhibitors
US-2025333420-A1 · Oct 30, 2025 · US
Bicyclic compounds as inhibitors of wrn
US-2025333419-A1 · Oct 30, 2025 · US
Recent patents
Latest publications not already listed above.
Tricyclic compounds as inhibitors of KRAS
US-12441727-B2 · Oct 14, 2025 · US
Naphthyridine compounds as inhibitors of KRAS
US-12441742-B2 · Oct 14, 2025 · US
Imidazopyrimidines and triazolopyrimidines as a2a / a2b inhibitors
US-2025313567-A1 · Oct 9, 2025 · US
Pyrrolotriazine compounds as tam inhibitors
US-12415809-B2 · Sep 16, 2025 · US
Imidaz0[1,2-a]pyrimidine-5(1 h)-ones as wrn inhibitors
US-2025270218-A1 · Aug 28, 2025 · US
Imidaz0[1,2-a]pyrimidine-5(1 h)-ones having a covalent warhead at the 3-position as wrn inhibitors
US-2025270217-A1 · Aug 28, 2025 · US
SPPL2a INHIBITORS
US-2025263416-A1 · Aug 21, 2025 · US
Quinoline compounds as inhibitors of KRAS
US-12378243-B2 · Aug 5, 2025 · US
Bicyclic compounds as inhibitors of wrn
US-2025236622-A1 · Jul 24, 2025 · US
Tricyclic compounds as inhibitors of wrn
US-2025215006-A1 · Jul 3, 2025 · US
Bicyclic heterocycles as mrgprx2 antagonists
US-2025206734-A1 · Jun 26, 2025 · US
Bicyclooctane kras inhibitors
US-2025195536-A1 · Jun 19, 2025 · US
Hetero-bicyclic inhibitors of KRAS
US-12331063-B2 · Jun 17, 2025 · US
COMBINATION THERAPY COMPRISING DGK INHIBITORS and PD-1/PD-L1 INHIBITORS
US-2025186450-A1 · Jun 12, 2025 · US
Tricyclic compounds as inhibitors of kras
US-2025188073-A1 · Jun 12, 2025 · US
Tricyclic triazolo compounds as dgk inhibitors
US-2025179083-A1 · Jun 5, 2025 · US
Kras inhibitors
US-2025163079-A1 · May 22, 2025 · US
Spirocyclic lactam inhibitors
US-2025101020-A1 · Mar 27, 2025 · US
Bicyclic heterocycles as mrgprx2 antagonists
US-2025084087-A1 · Mar 13, 2025 · US
Bicyclic heterocycles as mrgprx2 antagonists
US-2025084063-A1 · Mar 13, 2025 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Incyte Corp | 152 |
| Univ Pennsylvania | 3 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 135 |
| C07D487/04 | 81 |
| C07D471/04 | 72 |
| C07D519/00 | 63 |
| A61P29/00 | 41 |